Literature DB >> 29118172

Multicenter Evaluation of the Modified Carbapenem Inactivation Method and the Carba NP for Detection of Carbapenemase-Producing Pseudomonas aeruginosa and Acinetobacter baumannii.

Patricia J Simner1, J Kristie Johnson2, William B Brasso3, Karen Anderson4, David R Lonsway4, Virginia M Pierce5, April M Bobenchik6, Zabrina C Lockett7, Angella Charnot-Katsikas8, Lars F Westblade9, Brian B Yoo4, Stephen G Jenkins9, Brandi M Limbago4, Sanchita Das10, Darcie E Roe-Carpenter7.   

Abstract

The purpose of this study was to develop the modified carbapenem inactivation method (mCIM) for the detection of carbapenemase-producing Pseudomonas aeruginosa (CP-PA) and carbapenemase-producing Acinetobacter baumannii (CP-AB) and perform a multicenter evaluation of the mCIM and Carba NP tests for these nonfermenters. Thirty P. aeruginosa and 30 A. baumannii isolates previously characterized by whole-genome sequencing from the CDC-FDA Antibiotic Resistance Isolate Bank were evaluated, including CP isolates (Ambler class A, B, and D), non-carbapenemase-producing (non-CP) carbapenem-resistant isolates, and carbapenem-susceptible isolates. Initial comparison of a 1-μl versus 10-μl loop inoculum for the mCIM was performed by two testing sites and showed that 10 μl was required for reliable detection of carbapenemase production among P. aeruginosa and A. baumannii Ten testing sites then evaluated the mCIM using a 10-μl loop inoculum. Overall, the mean sensitivity and specificity of the mCIM for detection of CP-PA across all 10 sites were 98.0% (95% confidence interval [CI], 94.3 to 99.6; range, 86.7 to 100) and 95% (95% CI, 89.8 to 97.7; range, 93.3 to 100), whereas the mean sensitivity and specificity among CP-AB were 79.8% (95% CI, 74.0 to 84.9; range, 36.3 to 95.7) and 52.9% (95% CI, 40.6 to 64.9; range, 28.6 to 100), respectively. At three sites that evaluated the performance of the Carba NP test using the same set of isolates, the mean sensitivity and specificity of the Carba NP test were 97.8% (95% CI, 88.2 to 99.9; range, 93.3 to 100) and 97.8% (95% CI, 88.2 to 99.9; range, 93.3 to 100) for P. aeruginosa and 18.8% (95% CI, 10.4 to 30.1; range, 8.7 to 26.1) and 100% (95% CI, 83.9 to 100; range, 100) for A. baumannii Overall, we found both the mCIM and the Carba NP test to be accurate for detection of carbapenemase production among P. aeruginosa isolates and less reliable for use with A. baumannii isolates.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Acinetobacter baumannii; Carba NP; Pseudomonas aeruginosa; carbapenem resistance; carbapenemase; mCIM

Mesh:

Substances:

Year:  2017        PMID: 29118172      PMCID: PMC5744225          DOI: 10.1128/JCM.01369-17

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

Review 1.  Intestinal Carriage of Carbapenemase-Producing Organisms: Current Status of Surveillance Methods.

Authors:  Roberto Viau; Karen M Frank; Michael R Jacobs; Brigid Wilson; Keith Kaye; Curtis J Donskey; Federico Perez; Andrea Endimiani; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

Review 2.  Carbapenem-Resistant Non-Glucose-Fermenting Gram-Negative Bacilli: the Missing Piece to the Puzzle.

Authors:  Thomas J Gniadek; Karen C Carroll; Patricia J Simner
Journal:  J Clin Microbiol       Date:  2016-02-24       Impact factor: 5.948

3.  CarbAcineto NP test for rapid detection of carbapenemase-producing Acinetobacter spp.

Authors:  Laurent Dortet; Laurent Poirel; Caroline Errera; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2014-04-23       Impact factor: 5.948

4.  Comparison of 11 Phenotypic Assays for Accurate Detection of Carbapenemase-Producing Enterobacteriaceae.

Authors:  Pranita D Tamma; Belita N A Opene; Andrew Gluck; Krizia K Chambers; Karen C Carroll; Patricia J Simner
Journal:  J Clin Microbiol       Date:  2017-01-11       Impact factor: 5.948

Review 5.  Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology.

Authors:  Anaïs Potron; Laurent Poirel; Patrice Nordmann
Journal:  Int J Antimicrob Agents       Date:  2015-03-24       Impact factor: 5.283

6.  Emergence of carbapenem-resistant non-baumannii species of Acinetobacter harboring a blaOXA-51-like gene that is intrinsic to A. baumannii.

Authors:  Yi-Tzu Lee; Shu-Chen Kuo; Mei-Chun Chiang; Su-Pen Yang; Chien-Pei Chen; Te-Li Chen; Chang-Phone Fung
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

7.  Modified Carbapenem Inactivation Method for Phenotypic Detection of Carbapenemase Production among Enterobacteriaceae.

Authors:  Virginia M Pierce; Patricia J Simner; David R Lonsway; Darcie E Roe-Carpenter; J Kristie Johnson; William B Brasso; April M Bobenchik; Zabrina C Lockett; Angella Charnot-Katsikas; Mary Jane Ferraro; Richard B Thomson; Stephen G Jenkins; Brandi M Limbago; Sanchita Das
Journal:  J Clin Microbiol       Date:  2017-04-05       Impact factor: 5.948

8.  The carbapenem inactivation method (CIM), a simple and low-cost alternative for the Carba NP test to assess phenotypic carbapenemase activity in gram-negative rods.

Authors:  Kim van der Zwaluw; Angela de Haan; Gerlinde N Pluister; Hester J Bootsma; Albert J de Neeling; Leo M Schouls
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

9.  Evaluation of Six Phenotypic Methods for the Detection of Carbapenemases in Gram-Negative Bacteria With Characterized Resistance Mechanisms.

Authors:  Kunling Sun; Xiuyu Xu; Jinrong Yan; Liping Zhang
Journal:  Ann Lab Med       Date:  2017-07       Impact factor: 3.464

10.  Rapid identification of carbapenemase-producing Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii using a modified Carba NP test.

Authors:  S Bakour; V Garcia; L Loucif; J-M Brunel; A Gharout-Sait; A Touati; J-M Rolain
Journal:  New Microbes New Infect       Date:  2015-07-10
View more
  19 in total

1.  Evaluation of the Immunochromatographic NG-Test Carba 5 for Rapid Identification of Carbapenemase in Nonfermenters.

Authors:  Anaïs Potron; Damien Fournier; Cécile Emeraud; Pauline Triponney; Patrick Plésiat; Thierry Naas; Laurent Dortet
Journal:  Antimicrob Agents Chemother       Date:  2019-08-23       Impact factor: 5.191

2.  Biographical Feature: Stephen G. Jenkins, Ph.D., D(ABMM), F(AAM).

Authors:  Alexander J McAdam
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

Review 3.  Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates.

Authors:  Pranita D Tamma; Patricia J Simner
Journal:  J Clin Microbiol       Date:  2018-10-25       Impact factor: 5.948

4.  Rapid Detection and Characterization of Carbapenemases in Enterobacterales with a New Modified Carbapenem Inactivation Method, mCIMplus.

Authors:  Morgane Petit; François Caméléna; Aurélie Cointe; Thibaut Poncin; Manel Merimèche; Stéphane Bonacorsi; André Birgy; Béatrice Berçot
Journal:  J Clin Microbiol       Date:  2020-10-21       Impact factor: 5.948

5.  Evaluation of the Direct MacConkey Method for Identification of Carbapenem-Resistant Gram-Negative Organisms from Rectal Swabs: Reevaluating Zone Diameter Cutoffs.

Authors:  Meklit Workneh; Ruibin Wang; Abida Q Kazmi; Krizia K Chambers; Belita N A Opene; Shawna Lewis; Katherine Goodman; Pranita D Tamma; Karen C Carroll; Aaron M Milstone; Patricia J Simner
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948

Review 6.  Phenotypic and genotypic detection methods for antimicrobial resistance in ESKAPE pathogens (Review).

Authors:  Mădălina Maria Muntean; Andrei-Alexandru Muntean; Mădălina Preda; Loredana Sabina Cornelia Manolescu; Cerasella Dragomirescu; Mircea-Ioan Popa; Gabriela Loredana Popa
Journal:  Exp Ther Med       Date:  2022-06-09       Impact factor: 2.751

Review 7.  NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings.

Authors:  Wenjing Wu; Yu Feng; Guangmin Tang; Fu Qiao; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

8.  Evaluation of NG-Test Carba 5 for Rapid Phenotypic Detection and Differentiation of Five Common Carbapenemase Families: Results of a Multicenter Clinical Evaluation.

Authors:  Stephen Jenkins; Nathan A Ledeboer; Lars F Westblade; C A Burnham; Matthew L Faron; Patricia J Simner; Yehudit Bergman; Rebecca Yee; Brian Mesich; Derek Gerstbrein; Meghan A Wallace; Amy Robertson; Kathy A Fauntleroy; Anna S Klavins; Rianna Malherbe; Andre Hsiung
Journal:  J Clin Microbiol       Date:  2020-06-24       Impact factor: 5.948

9.  Evaluation of the EDTA-Modified Carbapenem Inactivation Method for Detecting Metallo-β-Lactamase-Producing Pseudomonas aeruginosa.

Authors:  Christian M Gill; Maxwell J Lasko; Tomefa E Asempa; David P Nicolau
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

10.  Detection and Characterization of Targeted Carbapenem-Resistant Health Care-Associated Threats: Findings from the Antibiotic Resistance Laboratory Network, 2017 to 2019.

Authors:  Sarah Sabour; Jennifer Y Huang; Amelia Bhatnagar; Sarah E Gilbert; Maria Karlsson; David Lonsway; Joseph D Lutgring; J Kamile Rasheed; Alison Laufer Halpin; Richard A Stanton; Stephanie Gumbis; Christopher A Elkins; Allison C Brown
Journal:  Antimicrob Agents Chemother       Date:  2021-09-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.